Most women in perimenopause and menopause should at least consider HRT. Modern bioidentical protocols (transdermal estradiol patch + oral micronized progesterone) carry a fundamentally different risk profile than the older synthetic hormone regimens that produced the alarming headlines in the early 2000s.
The timing hypothesis in the published menopause literature describes HRT initiated within 10 years of menopause or before age 60 as cardiovascular-protective, with the risk profile shifting when initiation is delayed. Start the conversation in your forties, not your sixties.
Treatment is daily-dose: a transdermal estradiol patch + 100-200 mg oral micronized progesterone (cyclic if perimenopause, continuous if postmenopause). Costs $199/mo at OPTML.
What this guide covers
Perimenopause vs menopause
Perimenopause is the 4-10 year transition before your final period, typically starting in the early 40s. Estrogen and progesterone production becomes erratic — high one month, low the next. The symptoms (sleep disruption, mood swings, brain fog, irregular cycles, weight gain around the midsection, joint stiffness, libido shifts) are caused by hormonal volatility, not low absolute levels.
Menopause is defined as 12 consecutive months without a period. Average age: 51. Ovarian estrogen production drops to near-zero and stays there. Progesterone effectively ceases. Hot flashes, night sweats, vaginal dryness, accelerated bone loss, accelerated muscle loss, and cardiovascular risk acceleration become the dominant symptoms.
Postmenopause is everything after the 12-month mark. The endocrine state is steady-low; the consequences (bone density loss, cardiovascular shift, urogenital changes) accumulate over decades.
Related: · menopause symptoms (actually) · .
What the hormone shifts actually cause
Estradiol affects nearly every tissue in a woman's body. When it leaves, a lot leaves with it.
- Brain: mood regulation, sleep architecture, cognitive function, vasomotor control (hot flashes).
- Bone: estrogen restrains osteoclast activity. Without it, bone density loss accelerates — typical postmenopausal woman loses 1-2% of bone density per year for the first 5-7 years.
- Cardiovascular: estrogen improves endothelial function, lipid profile (raises HDL, lowers LDL/ApoB), and arterial flexibility. Loss of estrogen is the proximate reason women catch up to men in CV mortality after age 60.
- Skin and collagen: ~30% of skin collagen is lost in the first 5 years of menopause.
- Urogenital: vaginal tissue, urethra, and pelvic floor all thin and lose elasticity. Recurrent UTIs and atrophic vaginitis are direct consequences.
- Body composition: resting metabolic rate drops; visceral fat increases independent of caloric intake.
Deeper reading: · · · .
The timing hypothesis
The unifying frame across the menopause-hormone-therapy reanalysis literature: HRT started within 10 years of menopause or before age 60 is cardiovascular-protective. HRT started after that window is neutral-to-harmful.
The biological logic: a freshly menopausal arterial wall still has the receptor density and tissue health to respond to estrogen. A 15-years-postmenopausal arterial wall has already accumulated atherosclerotic changes that estrogen exposure can destabilize.
Practical takeaway: HRT decisions belong in the perimenopause / early-menopause window, not as a retroactive intervention after a decade of symptoms.
Modern bioidentical HRT protocol
The OPTML default:
| Component | What | Why |
|---|---|---|
| Estradiol | Transdermal patch (0.05 mg/day typical start) | Bypasses first-pass liver metabolism, lower VTE/stroke risk than oral. Steady serum levels. |
| Progesterone | Oral micronized 100 mg daily (continuous, postmenopause) or 200 mg cyclic days 14-28 (perimenopause) | Endometrial protection. Bioidentical. Mild sedative effect — take at bedtime. |
| Testosterone (optional) | Low-dose compounded cream (1-2 mg/day) | For libido / energy / cognition support when estrogen replacement alone isn't sufficient. |
Bundle pricing at OPTML: $199/mo for estradiol patch + progesterone. Estradiol alone $79/mo. Progesterone alone $79/mo.
Articles: bioidentical vs synthetic HRT · transdermal vs oral estradiol · micronized progesterone explained.
What to expect on HRT
Weeks 1-2
Sleep usually improves first. Vasomotor symptoms (hot flashes, night sweats) start to soften by week 2. Some women feel mood lift within a week.
Months 1-3
Hot flashes typically reduced 70-90% from baseline. Sleep architecture more restorative. Mood baseline lifts. Vaginal dryness improves over 8-12 weeks. Joint stiffness eases for many women.
Months 3-6
Metabolic markers begin to shift — visceral fat plateaus or reverses with consistent training and protein. Cognitive clarity restored for most. Libido shifts for some (often paired with low-dose testosterone if libido remains the gap).
Beyond 6 months
Bone density preservation (slow accumulation visible by 18-24 months on DEXA). Cardiovascular biomarkers (lipid panel, ApoB) trend favorably. Long-term cognitive trajectories appear preserved (imaging substudy literature).
Side effects and contraindications
Common, mild
- Breast tenderness in the first 4-8 weeks (resolves)
- Mild bloating or fluid retention (resolves)
- Spotting in perimenopausal women on cyclic regimens (expected)
- Drowsiness from progesterone — dose at bedtime, this is a feature
Absolute contraindications
- Active or history of estrogen-receptor-positive breast cancer
- Active VTE / pulmonary embolism
- Active liver disease
- Unexplained vaginal bleeding (work up first)
- Pregnancy
Relative contraindications (require physician judgment)
- Prior VTE (transdermal is much lower risk than oral)
- Migraine with aura
- Uncontrolled hypertension
Articles: · · HRT and breast cancer (modern evidence).
Testosterone for women
Women produce testosterone too — roughly 1/10 the level of men, but it's metabolically significant. Levels decline gradually from the 20s onward, accelerating around menopause. Symptoms of low T in women: low libido (most common), low drive, reduced energy, cognitive fog despite adequate estrogen.
Low-dose compounded testosterone cream (1-2 mg/day applied to the inner thigh or labia) restores female-range testosterone without masculinizing effects. Off-label in the U.S., commonly used.
See · .
Frequently asked questions
Will HRT make me gain weight?
No. Weight is typically stable. The visceral fat accumulation many women notice in menopause is partly driven by declining estrogen. Some women retain a few pounds of fluid in the first 4-8 weeks; that resolves.
How long can I stay on HRT?
Modern guidelines do not impose an arbitrary stop date. Indefinite use is appropriate for many women if benefits outweigh risks at annual re-evaluation. The old "10 years and stop" rule was based on outdated interpretations of older hormone-therapy studies.
Is HRT going to cause breast cancer?
The absolute risk increase from modern bioidentical HRT is small (estimated 1-2 additional breast cancer cases per 1,000 women treated over 5 years; less than the risk from drinking 2 glasses of wine daily). For most women within the timing window, the bone, cardiovascular, cognitive, and quality-of-life benefits outweigh this.
Do I need a progestogen if I'm on estradiol?
Only if you have a uterus. Without a uterus (post-hysterectomy), estradiol alone is appropriate. With a uterus, progesterone is mandatory for endometrial protection.
Should I be doing this through a regular OB-GYN or a telehealth service?
Either is fine if the prescribing physician is comfortable with modern bioidentical protocols and the timing hypothesis. Many traditional OB-GYNs still default to "you're too old / you'll get cancer" framings inherited from the early-2000s public reaction to that study. If your local doc is dismissive, a specialty telehealth provider is a reasonable alternative.